David-Neto E et al. |
Longitudinal Pharmacokinetics of Everolimus When Combined With Low-level of Tacrolimus in Elderly Renal Transplant Recipients. |
2017 |
Transplantation |
pmid:27798513
|
Schwartz JJ et al. |
Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. |
2007 |
Transplantation |
pmid:17893604
|
Yamagami S et al. |
Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506. |
1997 |
Transplantation |
pmid:9233699
|
Ouyang J et al. |
Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections. |
2005 |
Transplantation |
pmid:15912108
|
Boyer O et al. |
Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil. |
2005 |
Transplantation |
pmid:15912111
|
Neuhaus P et al. |
Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. |
1995 |
Transplantation |
pmid:7530868
|
Tzakis AG et al. |
Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. |
2003 |
Transplantation |
pmid:12717207
|
Villanueva G and Baldwin D |
Rosiglitazone therapy of posttransplant diabetes mellitus. |
2005 |
Transplantation |
pmid:16340782
|
Numakura K et al. |
Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. |
2005 |
Transplantation |
pmid:16340785
|
Ashokkumar C et al. |
Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation. |
2011 |
Transplantation |
pmid:21747326
|
Shield CF et al. |
Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9422413
|
Stegall MD et al. |
Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. |
1997 |
Transplantation |
pmid:9422416
|
Takeguchi N et al. |
Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppressants FK506 and cyclosporine. |
1993 |
Transplantation |
pmid:7681229
|
Bundick RV et al. |
FK506 as an agonist to induce inhibition of interleukin 2 production. |
1992 |
Transplantation |
pmid:1374947
|
Casey MJ et al. |
Prolonged immunosuppression preserves nonsensitization status after kidney transplant failure. |
2014 |
Transplantation |
pmid:24717218
|
Kasahara M et al. |
Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor. |
2001 |
Transplantation |
pmid:11211185
|
Ovuworie CA et al. |
Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. |
2001 |
Transplantation |
pmid:11685108
|
Mourad G et al. |
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. |
2001 |
Transplantation |
pmid:11579299
|
Peloso LJ et al. |
The serum concentration of tacrolimus after ingesting omeprazole: a pilot study. |
2014 |
Transplantation |
pmid:25221905
|
Xue F et al. |
Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. |
2010 |
Transplantation |
pmid:20010326
|
Alhamad T et al. |
Targeting High Calcineurin Inhibitor Levels After Acute Rejection With Less Tremor: A New Strategy. |
2017 |
Transplantation |
pmid:28422926
|
Dominguez J et al. |
Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience. |
2000 |
Transplantation |
pmid:11063349
|
Jiang H et al. |
Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production. |
2002 |
Transplantation |
pmid:12085006
|
Shapiro R et al. |
Posttransplant diabetes in pediatric recipients on tacrolimus. |
1999 |
Transplantation |
pmid:10096540
|
Cooper MH et al. |
Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors. |
1994 |
Transplantation |
pmid:7509089
|
Lo A et al. |
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. |
2004 |
Transplantation |
pmid:15114090
|
Shoker A et al. |
Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. |
2000 |
Transplantation |
pmid:10949194
|
Wallia A et al. |
Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. |
2010 |
Transplantation |
pmid:20098286
|
Vivarelli M et al. |
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. |
2010 |
Transplantation |
pmid:20098287
|
Jacobson PA et al. |
Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium. |
2012 |
Transplantation |
pmid:22334041
|
Schneeberger S et al. |
Cytomegalovirus-related complications in human hand transplantation. |
2005 |
Transplantation |
pmid:16123716
|
McDiarmid SV et al. |
Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients. |
1993 |
Transplantation |
pmid:7685933
|
Borger P et al. |
Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells. |
2000 |
Transplantation |
pmid:10798763
|
Macedo C et al. |
Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation. |
2012 |
Transplantation |
pmid:22343334
|
Saad ER et al. |
Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. |
2008 |
Transplantation |
pmid:18360267
|
Lorber MI et al. |
A comparison of in vivo responses to cyclosporine, FK506, and rapamycin following allogeneic immune challenge. |
1991 |
Transplantation |
pmid:1713364
|
Maluccio M et al. |
Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. |
2003 |
Transplantation |
pmid:12923450
|
Mendez R et al. |
A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. |
2005 |
Transplantation |
pmid:16082323
|
Starzl TE et al. |
Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin. |
1991 |
Transplantation |
pmid:1718068
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|